Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

TT-OAD2 free base

Inquiry
Cat. No.: OB0425LY-095
Synonyms: 1246826-07-2; N-{(3S,8S)-3-{4-[(3,4-Dichlorophenyl)methoxy]phenyl}-7-[(1S)-1-phenylpropyl]-2,3,6,7,8,9-hexahydro[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl}-4-(2,3-dimethylpyridin-4-yl)-L-phenylalanine; (S)-2-((3S,8S)-3-(4-((3,4-Dichlorobenzyl)oxy)phenyl)-7-((S)-1-phenylpropyl)-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carboxamido)-3-(4-(2,3-dimethylpyridin-4-yl)phenyl)propanoic acid
Size: 50 mg; 100 mg; 250 mg
CAS No.: 1246826-07-2
Compound CID: 58327143
TT-OAD2 free base

Specification

Description: TT-OAD2 free base is a small molecule compound that play a role in regulating metabolic pathways.
Formula Weight: 856.83
Applications: TT-OAD2 free base can be used for pharmacodynamic assessment in metabolic diseases, especially in studies of glucolipid metabolism and obesity.
Storage: Storage at -20°C.
Formula: C50H47Cl2N3O6
Appearance: Solid
Purity: ≥95%
Pathway: GPCR/G protein
Target: Glucagon receptor

Library Information

Inquiry

Copyright © Protheragen. All rights reserves.